JPRN-UMIN000016746已完成未知
Multicenter Randomized Double-blind Controlled Trial on Efficacy of Lactobacillus gasseri OLL2716 for Helicobacter pylori infection: Impact of probiotics on dyspeptic symptoms - Efficacy of L. gasseri in dyspeptic subjects
Study group of LG0 个研究点目标入组 150 人开始时间: 2015年3月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •included organic disorders, such as gastric cancer, gastric ulcers, duodenal ulcers, pyloric stenosis, use of NSAIDs, antibiotic treatment before the study, use of PPIs or H2 antagonists, H. pylori eradication therapy within 6 months before the study, ingestion of yogurt or lactic acid bacteria beverages, and the use of antiflatulence agents.
研究者
相似试验
招募中
1 期
Randomized double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease or kidney transplantatioEUCTR2019-002570-31-FRAssitance Publique - Hôpitaux de Paris234
进行中（未招募）
1 期
Study on ozonated blood in COVID-19 severe pneumoniaCovid-19 pneumoniaEUCTR2020-005020-11-ESPolíclinica Nuestra Señora del Rosario30
进行中（未招募）
1 期
AMIKINHAL (AMIKACIN inhaled)Patient with mechanical ventilation through an endotracheal tubeMedDRA version: 19.1Level: LLTClassification code 10065153Term: Ventilator associated pneumoniaSystem Organ Class: 100000004862EUCTR2016-001054-17-FRCHRU de Tours850
已完成
不适用
Multicentre randomised controlled double blind trial of prednisolone in Duchenne Muscular Dystrophy (DMD)eurosciencesMusculoskeletal DiseasesISRCTN91883476Medical Research Council (MRC) (UK)
进行中（未招募）
不适用
A controlled randomized double-blind multi-center phase II study of FOLFOX6 or FOLFIRI combined with sorafenib versus placebo in second-line metastatic colorectal carcinoma - FOLFOX6/FOLFIRI plus Sorafenib in second-line Colorectal cancer (FOSCO)EUCTR2008-000803-26-DEAIO Studien gGmbH